CLINICAL_TRIALS
trial_result
· 2017-07-17
Clinical Trial Update: Study of Panobinostat in Patients With Neuroendocrine Tumors [Phase 2]
Summary
Phase 2 trial of panobinostat in patients with neuroendocrine tumors was terminated; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Neuroendocrine Tumors | Phase 2 | Status: TERMINATED | Results posted: 2017-07-17